Medical Malpractice, Health Care Costs, and Technology Adoption

医疗事故、医疗保健费用和技术采用

基本信息

  • 批准号:
    8278575
  • 负责人:
  • 金额:
    $ 27.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Members of the research and policy communities have pointed to rising malpractice costs as a key driver of medical cost growth over the last ten to fifteen years. However, most of the existing research on malpractice fails to estimate its impact on overall costs, and relies on empirical identification strategies that have recently been called into question. To fill this gap, we propose to study the impacts of malpractice risk by developing a new empirical strategy. Specifically, we propose to rely on changes in the propensities of juries to award high "pain and suffering" awards, and the effect these changes have on malpractice costs. We present an array of direct and indirect empirical evidence in favor of both the power and validity of this identification strategy. For example, variation in non-economic damages significantly predicts future medical costs, but the reverse is not true. We propose to link information on county-level jury verdicts to: data on Medicare claims, inpatient hospital admissions data from the National Inpatient Sample (NIS), individual-level data from the Medicare Current Beneficiary Survey (MCBS), hospital-level data from the American Hospital Association (AHA) database of member hospitals, and county-level data on Medicare costs. These data sources will allow us to study: (1) The net social benefits of malpractice risk, in terms of its impacts on medical costs and health; (2) The impact of malpractice risk on long-run technology adoption; and (3) The mechanisms underlying the impacts of malpractice, particularly its impacts on the medical output, along with the nature and intensity of medical care. This research informs public policy regarding tort reform and malpractice reform, both of which have considerable impacts on public health, along with medical spending in the private and public sector. PUBLIC HEALTH RELEVANCE: There is an enormous amount of controversy over whether and how the malpractice system affects medical costs and health care delivery. We will explore the net social benefits of the malpractice regime, along with the causal impact of malpractice risk on medical costs, health outcomes, medical output and intensity, and the adoption of new medical technologies.
研究和政策界的成员指出,在过去的十到十五年里,医疗事故成本的上升是医疗成本增长的关键驱动力。然而,大多数关于医疗事故的现有研究未能估计其对整体成本的影响,并且依赖于最近受到质疑的经验识别策略。为了填补这一空白,我们建议通过开发一种新的实证策略来研究医疗事故风险的影响。具体来说,我们建议依靠陪审团倾向的变化来裁定高额的“痛苦和折磨”赔偿金,以及这些变化对医疗事故费用的影响。我们提出了一系列直接和间接的经验证据,有利于这种识别策略的力量和有效性。例如,非经济损失的变化可以显著预测未来的医疗费用,但反之则不然。我们建议将县级陪审团裁决的信息与以下数据联系起来:医疗保险索赔数据、来自全国住院患者样本(NIS)的住院患者入院数据、来自医疗保险当前受益调查(MCBS)的个人数据、来自美国医院协会(AHA)成员医院数据库的医院数据以及县级医疗保险费用数据。这些数据源将使我们能够研究:(1)医疗事故风险的净社会效益,就其对医疗成本和健康的影响而言;(2)医疗事故风险对长期技术采用的影响;以及(3)医疗事故影响的潜在机制,特别是其对医疗产出的影响,沿着医疗保健的性质和强度。这项研究告知有关侵权改革和医疗事故改革的公共政策,这两个都有相当大的影响公共卫生,沿着医疗支出在私营和公共部门。公共卫生相关性:关于医疗事故制度是否以及如何影响医疗费用和医疗保健服务,存在着大量的争议。我们将探讨医疗事故制度的净社会效益,沿着医疗事故风险对医疗成本、健康结果、医疗产出和强度以及新医疗技术的采用的因果影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Medical malpractice reform: noneconomic damages caps reduced payments 15 percent, with varied effects by specialty.
医疗事故改革:非经济损害赔偿额上限减少 15%,不同专业的影响也不同。
  • DOI:
    10.1377/hlthaff.2014.0492
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seabury,SethA;Helland,Eric;Jena,AnupamB
  • 通讯作者:
    Jena,AnupamB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DARIUS N. LAKDAWALLA其他文献

DARIUS N. LAKDAWALLA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DARIUS N. LAKDAWALLA', 18)}}的其他基金

Medical Malpractice, Health Care Costs, and Technology Adoption
医疗事故、医疗保健费用和技术采用
  • 批准号:
    8049334
  • 财政年份:
    2009
  • 资助金额:
    $ 27.53万
  • 项目类别:
Medical Malpractice, Health Care Costs, and Technology Adoption
医疗事故、医疗保健费用和技术采用
  • 批准号:
    7845587
  • 财政年份:
    2009
  • 资助金额:
    $ 27.53万
  • 项目类别:
Medical Malpractice, Health Care Costs, and Technology Adoption
医疗事故、医疗保健费用和技术采用
  • 批准号:
    8097362
  • 财政年份:
    2009
  • 资助金额:
    $ 27.53万
  • 项目类别:
EFFECT OF MEDICAL MALPRACTICE ON COSTS & TECH ADOPTION
医疗事故对费用的影响
  • 批准号:
    6901739
  • 财政年份:
    2005
  • 资助金额:
    $ 27.53万
  • 项目类别:
EFFECT OF MEDICAL MALPRACTICE ON COSTS & TECH ADOPTION
医疗事故对费用的影响
  • 批准号:
    7066508
  • 财政年份:
    2005
  • 资助金额:
    $ 27.53万
  • 项目类别:
WHOM DOES MEDICARE BENEFIT
医疗保险对谁有利
  • 批准号:
    6771400
  • 财政年份:
    2004
  • 资助金额:
    $ 27.53万
  • 项目类别:
WHOM DOES MEDICARE BENEFIT
医疗保险对谁有利
  • 批准号:
    7095130
  • 财政年份:
    2004
  • 资助金额:
    $ 27.53万
  • 项目类别:
WHOM DOES MEDICARE BENEFIT
医疗保险对谁有利
  • 批准号:
    6936456
  • 财政年份:
    2004
  • 资助金额:
    $ 27.53万
  • 项目类别:
Unclaimed Injuries and Workers' Compensation Adequacy
无人认领的伤害和工伤赔偿充足性
  • 批准号:
    6661887
  • 财政年份:
    2002
  • 资助金额:
    $ 27.53万
  • 项目类别:
Unclaimed Injuries and Workers' Compensation Adequacy
无人认领的伤害和工伤赔偿充足性
  • 批准号:
    6477769
  • 财政年份:
    2002
  • 资助金额:
    $ 27.53万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.53万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 27.53万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 27.53万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了